Education
About Us
Working with TipRanks
Follow Us
Lemus David Insider Profile
4 Followers
Lemus David, Director at Sorrento Therapeutics, holds ― shares in Sorrento Therapeutics (Ticker: SRNE), holds 2.00K shares in Scilex Holding Company (Ticker: SCLX), holds ― shares in Silence Therapeutics (Ticker: SLN). Most recently, Lemus David ― shares of Sorrento Therapeutics on ― for an estimated value of ―.
Lemus David has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lemus David holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lemus David
Lemus David's Trading History
Sorrento Therapeutics
―
Director
―
―
Scilex Holding Company
Oct 18, 2024
Director
Informative Buy
1.80K
$692.00
Silence Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Lemus David's performance on stock
You May Also Like
Lemus David insider profile FAQ
What is the percentage of profitable transactions made by Lemus David?
The percentage of profitable transactions made by Lemus David is ―.
What is the average return per transaction made by Lemus David?
The average return per transaction made by Lemus David is ―.
What stocks does Lemus David hold?
Lemus David holds: SRNE, SCLX, SLN stocks.
What was Lemus David’s latest transaction?
Lemus David latest transaction was an Uninformative Buy of ―.
What was Lemus David's most profitable transaction?
Lemus David’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lemus David's role in Sorrento Therapeutics?
Lemus David's role in Sorrento Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.